(Q48514765)

English

TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

TRH potentiates behavioural changes following increased brain 5-hydroxytryptamine accumulation in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

behavioural change

1 reference

based on heuristic

inferred from title

author name string

Green AR

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

Grahame-Smith DG

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

language of work or name

0 references

publication date

1 October 1974

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

251

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

5475

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

524-526

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

21 January 2018

Norepinephrine in depressive reactions. A review

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

21 January 2018

Lithium Carbonate and Isocarboxazid—An Effective Drug Approach in Severe Depressions

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

21 January 2018

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of thyrotropin-releasing hormone in depression

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of previously intractable depressions with tranylcypromine and lithium

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

L-Prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of cats

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone

1 reference

https://api.crossref.org/works/10.1038%2F251524A0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/251524A0

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/4214262

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48514765&oldid=2209549207"